These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17484283)

  • 1. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
    Dahiya S; Pathak K
    Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
    Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization and dissolution enhancement of aceclofenac-hydroxypropyl beta-cyclodextrin binary systems.
    Dahiya S; Pathak K
    PDA J Pharm Sci Technol; 2006; 60(6):378-88. PubMed ID: 17260903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems.
    Mura P; Faucci MT; Parrini PL; Furlanetto S; Pinzauti S
    Int J Pharm; 1999 Mar; 179(1):117-28. PubMed ID: 10053208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of griseofulvin with cyclodextrins in solid binary systems.
    Veiga MD; Díaz PJ; Ahsan F
    J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complexation of nimesulide with beta-cyclodextrins.
    Vavia PR; Adhage NA
    Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.
    Rajendrakumar K; Madhusudan S; Pralhad T
    Eur J Pharm Biopharm; 2005 May; 60(1):39-46. PubMed ID: 15848054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
    Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
    Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
    Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
    Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes.
    Sri KV; Kondaiah A; Ratna JV; Annapurna A
    Drug Dev Ind Pharm; 2007 Mar; 33(3):245-53. PubMed ID: 17454057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approach of aceclofenac fast dissolving tablet.
    Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
    Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.